Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,360 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
N-(2-Amino-phenyl)-4-(heteroarylmethyl)-benzamides as new histone deacetylase inhibitors.
Vaisburg A, Paquin I, Bernstein N, Frechette S, Gaudette F, Leit S, Moradei O, Raeppel S, Zhou N, Bouchain G, Woo SH, Jin Z, Gillespie J, Wang J, Fournel M, Yan PT, Trachy-Bourget MC, Robert MF, Lu A, Yuk J, Rahil J, Macleod AR, Besterman JM, Li Z, Delorme D. Vaisburg A, et al. Among authors: gillespie j. Bioorg Med Chem Lett. 2007 Dec 15;17(24):6729-33. doi: 10.1016/j.bmcl.2007.10.050. Epub 2007 Oct 18. Bioorg Med Chem Lett. 2007. PMID: 17977726
MGCD0103, a novel isotype-selective histone deacetylase inhibitor, has broad spectrum antitumor activity in vitro and in vivo.
Fournel M, Bonfils C, Hou Y, Yan PT, Trachy-Bourget MC, Kalita A, Liu J, Lu AH, Zhou NZ, Robert MF, Gillespie J, Wang JJ, Ste-Croix H, Rahil J, Lefebvre S, Moradei O, Delorme D, Macleod AR, Besterman JM, Li Z. Fournel M, et al. Among authors: gillespie j. Mol Cancer Ther. 2008 Apr;7(4):759-68. doi: 10.1158/1535-7163.MCT-07-2026. Mol Cancer Ther. 2008. PMID: 18413790
Discovery of a novel and potent series of thieno[3,2-b]pyridine-based inhibitors of c-Met and VEGFR2 tyrosine kinases.
Claridge S, Raeppel F, Granger MC, Bernstein N, Saavedra O, Zhan L, Llewellyn D, Wahhab A, Deziel R, Rahil J, Beaulieu N, Nguyen H, Dupont I, Barsalou A, Beaulieu C, Chute I, Gravel S, Robert MF, Lefebvre S, Dubay M, Pascal R, Gillespie J, Jin Z, Wang J, Besterman JM, MacLeod AR, Vaisburg A. Claridge S, et al. Among authors: gillespie j. Bioorg Med Chem Lett. 2008 May 1;18(9):2793-8. doi: 10.1016/j.bmcl.2008.04.009. Epub 2008 Apr 9. Bioorg Med Chem Lett. 2008. PMID: 18434145
Discovery of N-(2-aminophenyl)-4-[(4-pyridin-3-ylpyrimidin-2-ylamino)methyl]benzamide (MGCD0103), an orally active histone deacetylase inhibitor.
Zhou N, Moradei O, Raeppel S, Leit S, Frechette S, Gaudette F, Paquin I, Bernstein N, Bouchain G, Vaisburg A, Jin Z, Gillespie J, Wang J, Fournel M, Yan PT, Trachy-Bourget MC, Kalita A, Lu A, Rahil J, MacLeod AR, Li Z, Besterman JM, Delorme D. Zhou N, et al. Among authors: gillespie j. J Med Chem. 2008 Jul 24;51(14):4072-5. doi: 10.1021/jm800251w. Epub 2008 Jun 21. J Med Chem. 2008. PMID: 18570366
Melanoma toolkit for early detection for primary care clinicians: a 1-year follow-up on outcomes.
Diehl K, Stoos E, Becker A, Orfaly VE, Nelson J, Gillespie J, Ng J, Tobey T, Latour E, Ludzik J, Berry EG, Geller AC, Jacobe H, Leitenberger J, McClanahan D, Tran J, Prasad S, Mengden-Koon S, Nelson KC, Petering R, Verdieck A, Savory S, Smith EH, Tofte S, Weinstock MA, White K, Wisco O, Curiel-Lewandrowski C, Swetter SM, Witkowski AM, Ferris L, Black S, Xu R, Xu S, Leachman S. Diehl K, et al. Among authors: gillespie j. Front Med (Lausanne). 2024 Dec 18;11:1500216. doi: 10.3389/fmed.2024.1500216. eCollection 2024. Front Med (Lausanne). 2024. PMID: 39744535 Free PMC article.
Discovery of MDI-114215: A Potent and Selective LIMK Inhibitor To Treat Fragile X Syndrome.
Baldwin AG, Foley DW, Collins R, Lee H, Jones DH, Wahab B, Waters L, Pedder J, Paine M, Feng GJ, Privitera L, Ashall-Kelly A, Thomas C, Gillespie JA, Schino L, Belelli D, Rocha C, Maussion G, Krahn AI, Durcan TM, Elkins JM, Lambert JJ, Atack JR, Ward SE. Baldwin AG, et al. Among authors: gillespie ja. J Med Chem. 2025 Jan 9;68(1):719-752. doi: 10.1021/acs.jmedchem.4c02694. Epub 2024 Dec 22. J Med Chem. 2025. PMID: 39711116 Free PMC article.
Discovery of 6α-Thiazolylcarboxamidonaltrexamine Derivative (NTZ) as a Potent and Central Nervous System Penetrant Opioid Receptor Modulator with Drug-like Properties for Potential Treatment of Opioid Use Disorder.
Huang B, Ma H, Pagare PP, Li M, Mendez RE, Gillespie JC, Poklis JL, Halquist MS, Stevens DL, Dewey WL, Selley DE, Zhang Y. Huang B, et al. Among authors: gillespie jc. ACS Pharmacol Transl Sci. 2024 Dec 5;7(12):4165-4182. doi: 10.1021/acsptsci.4c00593. eCollection 2024 Dec 13. ACS Pharmacol Transl Sci. 2024. PMID: 39698260
Zircon trace element evidence for early hydrothermal activity on Mars.
Gillespie J, Cavosie AJ, Fougerouse D, Ciobanu CL, Rickard WDA, Saxey DW, Benedix GK, Bland PA. Gillespie J, et al. Sci Adv. 2024 Nov 22;10(47):eadq3694. doi: 10.1126/sciadv.adq3694. Epub 2024 Nov 22. Sci Adv. 2024. PMID: 39576864 Free PMC article.
1,360 results